Sec. 1. 24 MRSA §2332-G, as reallocated by RR 1995, c. 2, §49 and affected by §50, is repealed.

Sec. 2. 24-A MRSA §2847-F, as reallocated by PL 1997, c. 370, Pt. H, §1, is repealed.

Sec. 3. 24-A MRSA §4222, sub-§3, as enacted by PL 1975, c. 503, is repealed.

Sec. 4. 24-A MRSA §4241, as enacted by PL 1995, c. 617, §5 and affected by §6, is repealed.

Sec. 5. 24-A MRSA §4301, sub-§1, as amended by PL 1997, c. 604, Pt. A, §1, is further amended to read:

1. Carrier. "Carrier" means an insurance company licensed in accordance with this Title, a health maintenance organization licensed pursuant to chapter 56, a preferred provider organization licensed pursuant to chapter 32, a nonprofit hospital or medical service organization licensed pursuant to Title 24 or, a multiple-employer welfare arrangement licensed pursuant to chapter 81 or an employer maintaining an uninsured employee health plan described in section 2848-A or an employer maintaining or an insurer providing employee benefit excess insurance defined in section 707, subsection 1, paragraph C-1 for medical claims. An employer exempted from the applicability of this chapter under the federal Employee Retirement Income Security Act of 1974, 29 United States Code, Sections 1001 to 1461 (1988) is not considered a carrier.

Sec. 6. 24-A MRSA §4301, sub-§§1-A, 2-A, 2-B, 4-A and 4-B are enacted to read:

1-A.__Approved clinical trial.__"Approved clinical trial" means:

A.__A clinical research study or clinical investigation approved and funded, including funding through in-kind contributions, by the National Institutes of Health or a cooperative group or center of the National Institutes of Health; or

B.__A study or investigation that has been reviewed and approved through a system of peer review that is comparable to the system of peer review of studies and investigations used by the National Institutes of Health and that ensures unbiased review of the highest scientific standards by